Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Rutten (Cambridge, United Kingdom), S. Young (Cambridge, United Kingdom), N. Kurian (Gothenburg, Sweden), R. Hidi (Cambridge, United Kingdom), G. Hughes (Cambridge, United Kingdom). Eosinophil-derived neurotoxin (EDN) in healthy and asthmatic volunteers. 4458

Member's Comments

No comment yet.

Related content which might interest you: Point of care measurement of eosinophil derived neurotoxin (EDN) as a biomarker of eosinophilic asthma Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Eotaxin in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 163s Year: 2004 Involvement of 5-lipoxygenase (5-LO) pathway in eosinophil chemotaxis to acetylsalicylic acid (ASA) in aspirin-sensitive and healthy non-allergic subjects Source: Eur Respir J 2002; 20: Suppl. 38, 382s Year: 2002 Serum level of tryptase in atopic and non-atopic asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005 Serum and sputum interleukin-8: comparison between normal and allergic asthmatics children Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003 Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Lung deposition of formoterol HFA in healthy volunteers, asthmatic and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005 Lipopolysaccharide challenge in healthy smokers Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Allergic inflammation in serum and sputum: comparison between healthy controls and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 393s Year: 2004 Repeatibility of eNO measurements in asthmatic and healthy children Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma Year: 2003 Eicosanoid concentrations in induced sputum (IS) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA) Source: Eur Respir J 2005; 26: Suppl. 49, 575s Year: 2005 Aminoguanidine inhibits bronchial NO production, but not diffusion or alveolar NO in patients with asthma, smokers and healthy volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004 Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005 Pharmacological assessment of the effects of SB-705498 on capsaicin-induced responses in healthy volunteers and patients with non-allergic rhinitis Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Endotoxin exposure increases LL-37, but not calprotectin, in healthy human airways Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 EBC Cys-LT are increased in children with exercise induced bronchoconstriction (EIB) Source: Annual Congress 2004 - Monitoring childhood asthma Year: 2004 Reproducebility and safety of endotoxin inhalation in healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004 Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002 Tachyphylaxis to methacholine changes the dose-response curve in healthy non-asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004